Literature DB >> 1973619

Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell line.

J G Reeve1, P H Rabbitts, P R Twentyman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1973619      PMCID： PMC1971670          DOI： 10.1038/bjc.1990.190

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  37 in total

1.  Expression of a multidrug-resistance gene in human tumors and tissues.

Authors:  A T Fojo; K Ueda; D J Slamon; D G Poplack; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

2.  Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells.

Authors:  M B Meyers; V J Merluzzi; B A Spengler; J L Biedler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.

Authors:  A R Safa; C J Glover; J L Sewell; M B Meyers; J L Biedler; R L Felsted
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

5.  Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene.

Authors:  D W Shen; A Fojo; I B Roninson; J E Chin; R Soffir; I Pastan; M M Gottesman
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

6.  Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.

Authors:  I B Roninson; J E Chin; K G Choi; P Gros; D E Housman; A Fojo; D W Shen; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.

Authors:  M C Willingham; M M Cornwell; C O Cardarelli; M M Gottesman; I Pastan
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

8.  Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.

Authors:  S E Mirski; J H Gerlach; S P Cole
Journal:  Cancer Res       Date:  1987-05-15       Impact factor: 12.701

9.  Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.

Authors:  M M Cornwell; I Pastan; M M Gottesman
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

10.  A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain.

Authors:  A M Van der Bliek; M B Meyers; J L Biedler; E Hes; P Borst
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598
View more
  14 in total

Review 1.  Cellular models for multiple drug resistance in cancer.

Authors:  M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

2.  Preclinical pharmacology of 1069C85, a novel tubulin binder.

Authors:  F I Raynaud; L R Kelland; M I Walton; I R Judson
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours.

Authors:  T W Beer; D C Rowlands; J Crocker
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

Review 4.  Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug.

Authors:  M S Center
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 5.  Human cell lines as models for multidrug resistance in solid tumours.

Authors:  M Clynes; M Heenan; K Hall
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 6.  Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro.

Authors:  B T Hill
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

7.  Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.

Authors:  H M Coley; P Workman; P R Twentyman
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

8.  Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.

Authors:  H M Coley; W B Amos; P R Twentyman; P Workman
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

9.  Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.

Authors:  S P Cole; M J Pinkoski; G Bhardwaj; R G Deeley
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

10.  A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.

Authors:  T Rhodes; P R Twentyman
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.